drugset / Trial / NCT05254574

Sustained Acoustic Medicine for Osteoarthritis Pain

NCT05254574

Phase 1 Recruiting 200 enrolled ZetrOZ, Inc.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to compare Sustained Acoustic Medicine treatment to topical pain relief gel for the symptomatic management of osteoarthritis. The study will measure pain and function scores for patients undergoing treatment.

Timeline

Start
2022-02-14
Primary completion
2026-05-01
Completion
2026-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified 2.5 % Topical

Indications